Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer : Current knowledge and future directionsPAO, William; MILLER, Vincent A.Journal of clinical oncology. 2005, Vol 23, Num 11, pp 2556-2568, issn 0732-183X, 13 p.Article

Optimizing therapy in previously treated non-small cell lung cancerMILLER, Vincent A.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S25-S31, SUP1Article

Small cell lung cancerKRUG, Lee M; MILLER, Vincent A.Seminars in oncology. 2003, Vol 30, Num 1, issn 0093-7754, 108 p.Serial Issue

BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK InhibitionHUTCHINSON, Katherine E; LIPSON, Doron; PUZANOV, Igor et al.Clinical cancer research (Print). 2013, Vol 19, Num 24, pp 6696-6702, issn 1078-0432, 7 p.Article

D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast CancerMERENBAKH-LAMIN, Keren; BEN-BARUCH, Noa; RIZEL, Shulamith et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 23, pp 6856-6864, issn 0008-5472, 9 p.Article

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 TrialJÄNNE, Pasi A; XIAOFEI WANG; VOKES, Everett E et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2063-2069, issn 0732-183X, 7 p.Article

Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to ErlotinibJANJIGIAN, Yelena Y; AZZOLI, Christopher G; RIELY, Gregory J et al.Clinical cancer research (Print). 2011, Vol 17, Num 8, pp 2521-2527, issn 1078-0432, 7 p.Article

Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung AdenocarcinomaBEAN, James; RIELY, Gregory J; BALAK, Marissa et al.Clinical cancer research (Print). 2008, Vol 14, Num 22, pp 7519-7525, issn 1078-0432, 7 p.Article

Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung AdenocarcinomaRIELY, Gregory J; KRIS, Mark G; MILLER, Vincent A et al.Clinical cancer research (Print). 2008, Vol 14, Num 18, pp 5731-5734, issn 1078-0432, 4 p.Article

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumorsFURY, Matthew G; SOLIT, David B; PIZZO, Barbara A et al.Cancer chemotherapy and pharmacology. 2007, Vol 59, Num 4, pp 467-475, issn 0344-5704, 9 p.Article

Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimusRIELY, Gregory J; KRIS, Mark G; MILLER, Vincent A et al.Clinical cancer research. 2007, Vol 13, Num 17, pp 5150-5155, issn 1078-0432, 6 p.Article

Gemcitabine-induced peripheral edema: Report on 15 cases and review of the literatureAZZOLI, Christopher G; MILLER, Vincent A; NG, Kenneth K et al.American journal of clinical oncology. 2003, Vol 26, Num 3, pp 247-251, issn 0277-3732, 5 p.Article

Surgical treatment of small cell lung cancerSZCZESNY, Tomasz J; SZCZESNA, Aleksandra; SHEPHERD, Frances A et al.Seminars in oncology. 2003, Vol 30, Num 1, pp 47-56, issn 0093-7754, 10 p.Article

Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. DiscussionEBRIGHT, Michael I; ZAKOWSKI, Maureen F; WOOD, Douglas E et al.The Annals of thoracic surgery. 2002, Vol 74, Num 5, pp 1640-1647, issn 0003-4975, 8 p.Conference Paper

EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung AdenocarcinomaMAI HE; CAPELLETTI, Marzia; JÄNNE, Pasi A et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1790-1797, issn 1078-0432, 8 p.Article

Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based AssayARCILA, Maria E; OXNARD, Geoffrey R; NAFA, Khedoudja et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 1169-1180, issn 1078-0432, 12 p.Article

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFRBIVONA, Trever G; HIERONYMUS, Haley; HANNON, Gregory et al.Nature (London). 2011, Vol 471, Num 7339, pp 523-526, issn 0028-0836, 4 p.Article

Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non-Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical TrialsJACKMAN, David M; MILLER, Vincent A; CIOFFREDI, Leigh-Anne et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5267-5273, issn 1078-0432, 7 p.Article

Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non-Small-Cell Lung CancerRIELY, Gregory J; RIZVI, Naiyer A; SESHAN, Venkatraman E et al.Journal of clinical oncology. 2009, Vol 27, Num 2, pp 264-270, issn 0732-183X, 7 p.Article

Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non-Small-Cell Lung CancerRIZVI, Naiyer A; RIELY, Gregory J; KRIS, Mark G et al.Journal of clinical oncology. 2008, Vol 26, Num 4, pp 639-643, issn 0732-183X, 5 p.Article

A phase 1 study of Pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumorsAZZOLI, Christopher G; KRUG, Lee M; PIZZO, Barbara et al.Clinical cancer research. 2007, Vol 13, Num 9, pp 2692-2698, issn 1078-0432, 7 p.Article

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon19 and exon 21 mutations treated with gefitinib or erlotinibRIELY, Gregory J; PAO, William; PHAM, Duykhanh et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 839-844, issn 1078-0432, 6 p., 1Article

Update on epidermal growth factor receptor mutations in non-small cell lung cancerRIELY, Gregory J; POLITI, Katerina A; MILLER, Vincent A et al.Clinical cancer research. 2006, Vol 12, Num 24, pp 7232-7241, issn 1078-0432, 10 p.Article

Prophylactic cranial irradiation in small cell lung cancerVINES, Eugenio F; LE PECHOUX, Cécile; ARRIAGADA, Rodrigo et al.Seminars in oncology. 2003, Vol 30, Num 1, pp 38-46, issn 0093-7754, 9 p.Article

A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasisDOWNEY, Robert J; NG, Kenneth K; KRIS, Mark G et al.Lung cancer. 2002, Vol 38, Num 2, pp 193-197, issn 0169-5002, 5 p.Article